An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome-Reference-Cited by-同舟云学术

An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome

Published:2016-01 Issue: Volume:221 Page:1-8
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Wibroe Peter P.,Ahmadvand Davoud,Oghabian Mohammad Ali,Yaghmur Anan,Moghimi S. Moein

Funder

Danish Agency for Science, Technology and Innovation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Doxil® — the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012

2. Nanomedicines: addressing the scientific and regulatory gap;Tinkle;Ann. N.Y. Acad. Sci.,2014

3. Defining and characterizing nonbiological complex drugs (NBCDs) — is size enough? The case for liposomal doxorubicin generics (‘liposomal nanosimilars’) for injection;Moghimi;GaBI J.,2014

4. Access to liposomal generic formulations: beyond AmBisome and Doxil/Caelyx;Gaspani;GaBI J.,2013

5. Reshaping the future of nanopharmaceuticals: ad iudicium;Moghimi;ACS Nano,2011

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telomerase Modulating of Breast Cancer Through Nano-Based Drug Delivery System;Indian Journal of Gynecologic Oncology;2024-09

2. Scalable microfluidic method for tunable liposomal production by a design of experiment approach;International Journal of Pharmaceutics;2024-09

3. Lipidic and Polymeric Nanomedicines in Clinical Applications;Nanotechnology in Therapeutics;2024-07-26

4. Perilous paradigm of graphene oxide and its derivatives in biomedical applications: Insight to immunocompatibility;Biomedicine & Pharmacotherapy;2024-07

5. Liposomes Enhance the Immunological Activity of Polygonatum Cyrtonema Hua Polysaccharides;Journal of Pharmaceutical Sciences;2024-06